NEA Management Company, LLC Long-Term Concentrated

CIK: 0001512848 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 7, 2019

Total Value ($000): $1,427,496 (100.0% shares, 0.0% debt)

Holdings (44)

— RA PHARMACEUTICALS INC 12.9%

Value ($000) $184,594 Shares 6,138,797 Est. Cost $12.29 Unrealized —

— GLYCOMIMETICS INC 7.6%

Value ($000) $108,341 Shares 9,089,041 Est. Cost $16.32 Unrealized —

RYTM RHYTHM PHARMACEUTICALS INC 7.6%

Value ($000) $108,071 Shares 4,912,306 Est. Cost $26.40 Unrealized -4.3%

CRSP CRISPR THERAPEUTICS AG 6.9%

Value ($000) $98,471 Shares 2,090,678 Est. Cost $20.40 Unrealized +95.9%

— ALLAKOS INC 6.9%

Value ($000) $98,281 Shares 2,268,188 Est. Cost $44.99 Unrealized —

— PHASEBIO PHARMACEUTICALS INC 6.1%

Value ($000) $87,165 Shares 6,643,704 Est. Cost $13.12 Unrealized —

ADAPY ADAPTIMMUNE THERAPEUTICS PLC 4.5%

Value ($000) $63,647 Shares 15,832,611 Est. Cost $8.89 Unrealized —

— SENSEONICS HOLDINGS INC 4.4%

Value ($000) $63,012 Shares 30,888,266 Est. Cost $2.63 Unrealized —

— EPIZYME INC 3.8%

Value ($000) $54,938 Shares 4,377,518 Est. Cost $23.60 Unrealized —

— OBSEVA SA 3.6%

Value ($000) $51,874 Shares 4,586,563 Est. Cost $10.23 Unrealized —

— MERSANA THERAPEUTICS INC 3.4%

Value ($000) $48,172 Shares 11,894,267 Est. Cost $11.22 Unrealized —

ARDX ARDELYX INC 2.9%

Value ($000) $41,251 Shares 15,335,047 Est. Cost $12.05 Unrealized -75.0%

— MARKER THERAPEUTICS INC 2.8%

Value ($000) $39,600 Shares 5,000,000 Est. Cost $5.55 Unrealized —

— SYNLOGIC INC 2.7%

Value ($000) $38,488 Shares 4,229,410 Est. Cost $18.08 Unrealized —

AUPH AURINIA PHARMACEUTICALS INC 2.4%

Value ($000) $34,036 Shares 5,172,683 Est. Cost $3.82 Unrealized +66.7%

— DERMIRA INC 2.3%

Value ($000) $33,524 Shares 3,506,649 Est. Cost $15.35 Unrealized —

TRVI TREVI THERAPEUTICS INC 2.3%

Value ($000) $33,224 Shares 4,429,804 Est. Cost $8.61 Unrealized 0.0%

— GENOCEA BIOSCIENCES INC 2.0%

Value ($000) $28,325 Shares 7,225,676 Est. Cost $0.92 Unrealized —

— MILLENDO THERAPEUTICS INC 1.4%

Value ($000) $20,424 Shares 1,766,779 Est. Cost $7.95 Unrealized —

LQDA LIQUIDIA TECHNOLOGIES INC 1.4%

Value ($000) $19,888 Shares 2,486,062 Est. Cost $16.43 Unrealized -42.9%

— AVEO PHARMACEUTICALS INC 1.2%

Value ($000) $16,913 Shares 25,243,865 Est. Cost $1.04 Unrealized —

BE BLOOM ENERGY CORP 1.1%

Value ($000) $16,360 Shares 1,333,333 Est. Cost $27.96 Unrealized -56.1%

LXRX LEXICON PHARMACEUTICALS INC 1.0%

Value ($000) $14,985 Shares 2,382,286 Est. Cost $12.29 Unrealized -51.3%

— AFFIMED NV 1.0%

Value ($000) $14,749 Shares 5,138,888 Est. Cost $2.19 Unrealized —

— MEI PHARMA INC 1.0%

Value ($000) $14,301 Shares 5,720,572 Est. Cost $3.94 Unrealized —

— STRONGBRIDGE BIOPHARMA PLC 0.9%

Value ($000) $12,962 Shares 4,141,308 Est. Cost $5.09 Unrealized —

— DASAN ZHONE SOLUTIONS INC 0.9%

Value ($000) $12,422 Shares 956,255 Est. Cost $6.25 Unrealized —

CSBR CHAMPIONS ONCOLOGY INC 0.9%

Value ($000) $12,234 Shares 1,562,500 Est. Cost $6.08 Unrealized +44.2%

— SURFACE ONCOLOGY INC 0.7%

Value ($000) $9,349 Shares 3,315,149 Est. Cost $16.31 Unrealized —

— RIGEL PHARMACEUTICALS INC 0.6%

Value ($000) $8,465 Shares 3,243,150 Est. Cost $3.34 Unrealized —

— VERONA PHARMA PLC 0.4%

Value ($000) $6,220 Shares 1,219,674 Est. Cost $13.33 Unrealized —

— PROTEOSTASIS THERAPEUTICS INC 0.4%

Value ($000) $5,418 Shares 5,556,778 Est. Cost $8.76 Unrealized —

— X4 PHARMACEUTICALS INC 0.4%

Value ($000) $5,000 Shares 333,333 Est. Cost $17.41 Unrealized —

— ERYTECH PHARMA SA 0.3%

Value ($000) $4,469 Shares 625,000 Est. Cost $22.02 Unrealized —

— TREVENA INC 0.3%

Value ($000) $3,926 Shares 3,811,691 Est. Cost $7.47 Unrealized —

— CTI BIOPHARMA CORP 0.2%

Value ($000) $3,222 Shares 3,750,000 Est. Cost $3.90 Unrealized —

— REGULUS THERAPEUTICS INC 0.2%

Value ($000) $2,566 Shares 2,052,455 Est. Cost $1.11 Unrealized —

— TRACON PHARMACEUTICALS INC 0.2%

Value ($000) $2,358 Shares 3,467,181 Est. Cost $9.35 Unrealized —

— ENDOLOGIX INC 0.1%

Value ($000) $1,803 Shares 249,021 Est. Cost $8.36 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.1%

Value ($000) $1,802 Shares 182,754 Est. Cost $9.57 Unrealized 0.0%

— SUNESIS PHARMACEUTICALS INC 0.1%

Value ($000) $943 Shares 1,298,274 Est. Cost $4.37 Unrealized —

— AKARI THERAPEUTICS PLC 0.1%

Value ($000) $913 Shares 452,167 Est. Cost $13.49 Unrealized —

— TRILLIUM THERAPEUTICS INC 0.0%

Value ($000) $691 Shares 2,100,000 Est. Cost $3.16 Unrealized —

— ACHAOGEN INC 0.0%

Value ($000) $99 Shares 5,215,128 Est. Cost $4.67 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RA PHARMACEUTICALS INC	6,138,797	$184,594	12.9%	$12.29	—	COM	74933V108
—	GLYCOMIMETICS INC	9,089,041	$108,341	7.6%	$16.32	—	COM	38000Q102
RYTM	RHYTHM PHARMACEUTICALS INC	4,912,306	$108,071	7.6%	$26.40	-4.3%	COM	76243J105
CRSP	CRISPR THERAPEUTICS AG	2,090,678	$98,471	6.9%	$20.40	+95.9%	NAMEN AKT	H17182108
—	ALLAKOS INC	2,268,188	$98,281	6.9%	$44.99	—	COM	01671P100
—	PHASEBIO PHARMACEUTICALS INC	6,643,704	$87,165	6.1%	$13.12	—	COM	717224109
ADAPY	ADAPTIMMUNE THERAPEUTICS PLC	15,832,611	$63,647	4.5%	$8.89	—	ADR	00653A107
—	SENSEONICS HOLDINGS INC	30,888,266	$63,012	4.4%	$2.63	—	COM	81727U105
—	EPIZYME INC	4,377,518	$54,938	3.8%	$23.60	—	COM	29428V104
—	OBSEVA SA	4,586,563	$51,874	3.6%	$10.23	—	COM	H5861P103
—	MERSANA THERAPEUTICS INC	11,894,267	$48,172	3.4%	$11.22	—	COM	59045L106
ARDX	ARDELYX INC	15,335,047	$41,251	2.9%	$12.05	-75.0%	COM	039697107
—	MARKER THERAPEUTICS INC	5,000,000	$39,600	2.8%	$5.55	—	COM	57055L107
—	SYNLOGIC INC	4,229,410	$38,488	2.7%	$18.08	—	COM	87166L100
AUPH	AURINIA PHARMACEUTICALS INC	5,172,683	$34,036	2.4%	$3.82	+66.7%	COM	05156V102
—	DERMIRA INC	3,506,649	$33,524	2.3%	$15.35	—	COM	24983L104
TRVI	TREVI THERAPEUTICS INC	4,429,804	$33,224	2.3%	$8.61	0.0%	COM	89532M101
—	GENOCEA BIOSCIENCES INC	7,225,676	$28,325	2.0%	$0.92	—	COM	372427104
—	MILLENDO THERAPEUTICS INC	1,766,779	$20,424	1.4%	$7.95	—	COM	60040X103
LQDA	LIQUIDIA TECHNOLOGIES INC	2,486,062	$19,888	1.4%	$16.43	-42.9%	COM	53635D202
—	AVEO PHARMACEUTICALS INC	25,243,865	$16,913	1.2%	$1.04	—	COM	053588109
BE	BLOOM ENERGY CORP	1,333,333	$16,360	1.1%	$27.96	-56.1%	COM CL A	093712107
LXRX	LEXICON PHARMACEUTICALS INC	2,382,286	$14,985	1.0%	$12.29	-51.3%	COM NEW	528872302
—	AFFIMED NV	5,138,888	$14,749	1.0%	$2.19	—	COM	N01045108
—	MEI PHARMA INC	5,720,572	$14,301	1.0%	$3.94	—	COM NEW	55279B202
—	STRONGBRIDGE BIOPHARMA PLC	4,141,308	$12,962	0.9%	$5.09	—	SHS USD	G85347105
—	DASAN ZHONE SOLUTIONS INC	956,255	$12,422	0.9%	$6.25	—	COM NEW	23305L206
CSBR	CHAMPIONS ONCOLOGY INC	1,562,500	$12,234	0.9%	$6.08	+44.2%	COM NEW	15870P307
—	SURFACE ONCOLOGY INC	3,315,149	$9,349	0.7%	$16.31	—	COM	86877M209
—	RIGEL PHARMACEUTICALS INC	3,243,150	$8,465	0.6%	$3.34	—	COM NEW	766559603
—	VERONA PHARMA PLC	1,219,674	$6,220	0.4%	$13.33	—	ADS	925050106
—	PROTEOSTASIS THERAPEUTICS INC	5,556,778	$5,418	0.4%	$8.76	—	COM	74373B109
—	X4 PHARMACEUTICALS INC	333,333	$5,000	0.4%	$17.41	—	COM	98420X103
—	ERYTECH PHARMA SA	625,000	$4,469	0.3%	$22.02	—	ADR	29604W108
—	TREVENA INC	3,811,691	$3,926	0.3%	$7.47	—	COM	89532E109
—	CTI BIOPHARMA CORP	3,750,000	$3,222	0.2%	$3.90	—	COM NEW	12648L601
—	REGULUS THERAPEUTICS INC	2,052,455	$2,566	0.2%	$1.11	—	COM NEW	75915K200
—	TRACON PHARMACEUTICALS INC	3,467,181	$2,358	0.2%	$9.35	—	COM	89237H100
—	ENDOLOGIX INC	249,021	$1,803	0.1%	$8.36	—	COM	29266S106
XENE	XENON PHARMACEUTICALS INC	182,754	$1,802	0.1%	$9.57	0.0%	COM	98420N105
—	SUNESIS PHARMACEUTICALS INC	1,298,274	$943	0.1%	$4.37	—	COM PAR	867328700
—	AKARI THERAPEUTICS PLC	452,167	$913	0.1%	$13.49	—	ADR	00972G108
—	TRILLIUM THERAPEUTICS INC	2,100,000	$691	0.0%	$3.16	—	COM NEW	89620X506
—	ACHAOGEN INC	5,215,128	$99	0.0%	$4.67	—	COM	004449104